[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  3SBio Inc. 3SBio Inc. stock soars following a $X billion deal with Pfizer. Positive sentiment and high engagement are driving the price to an all-time high. ### About 3SBio Inc. 3SBio Inc. is a Chinese biopharmaceutical company. ### Insights [#](/topic/$1530hk/insights) - 3SBio Inc. posts created is up XXX% from the previous week. - 3SBio Inc. Price hit a high of XXXXX for the hour - 3SBio Inc. Price hit an all time of XXXXX for the hour ### Price: $ [#](/topic/$1530hk/close) ---  [Price 24-Hour Chart Data](/topic/$1530hk/time-series/close.tsv) The price surge to an all-time high of $XXXXX is likely due to positive social media sentiment and high engagement surrounding Pfizer's licensing deal and equity investment. **1-Year High**: $XXXXX on 2025-07-17 **1-Year Low**: $XXXX on 2024-11-22 ### AltRank: undefined [#](/topic/$1530hk/alt_rank) ---  [AltRank 24-Hour Chart Data](/topic/$1530hk/time-series/alt_rank.tsv) 3SBio Inc. is currently AltRank #undefined based on combined combined social and market metrics **Daily Average**: XXXXX **1-Year High**: XXXXX on 2025-01-28 **1-Year Low**: XXX on 2025-03-28 ### Galaxy Score: XX [#](/topic/$1530hk/galaxy_score) ---  [Galaxy Score 24-Hour Chart Data](/topic/$1530hk/time-series/galaxy_score.tsv) **Current Value**: XX **Daily Average**: XX **1-Year High**: XXX on 2025-03-24 **1-Year Low**: XX on 2025-02-15 ### Engagements: XXX [#](/topic/$1530hk/interactions) ---  [Engagements 24-Hour Chart Data](/topic/$1530hk/time-series/interactions.tsv) **Current Value**: XXX **Daily Average**: XXXXX **1 Week**: XXXXX -XX% **1 Month**: XXXXXX -XX% **6 Months**: XXXXXXX +128,724% **1 Year**: XXXXXXX +64,494% **1-Year High**: XXXXXXX on 2025-05-20 **1-Year Low**: X on 2025-02-09 | Social Network | News | X | Reddit | YouTube | | -------------- | ---- | - | ------ | ------- | | Engagements | X | XX | X | XX | ### Mentions: X [#](/topic/$1530hk/posts_active) ---  [Mentions 24-Hour Chart Data](/topic/$1530hk/time-series/posts_active.tsv) **Current Value**: X **Daily Average**: XX **1 Week**: XX +6.90% **1 Month**: XX -XX% **6 Months**: XXX +5,333% **1 Year**: XXX +1,938% **1-Year High**: XXX on 2025-05-20 **1-Year Low**: X on 2024-08-07 | Social Network | News | X | Reddit | YouTube | | -------------- | ---- | - | ------ | ------- | | Mentions | X | XX | X | X | ### Creators: X [#](/topic/$1530hk/contributors_active) ---  [Creators 24-Hour Chart Data](/topic/$1530hk/time-series/contributors_active.tsv) X unique social accounts have posts mentioning 3SBio Inc. in the last XX hours which is down XX% from XX in the previous XX hours **Daily Average**: XX **1 Week**: XX +6.40% **1 Month**: XX -XX% **6 Months**: XXX +6,050% **1 Year**: XXX +2,633% **1-Year High**: XXX on 2025-05-20 **1-Year Low**: X on 2024-08-07 ### Sentiment: XXX% [#](/topic/$1530hk/sentiment) ---  [Sentiment 24-Hour Chart Data](/topic/$1530hk/time-series/sentiment.tsv) **Current Value**: XXX% **Daily Average**: XX% **1 Week**: XX% -XX% **1 Month**: XX% -X% **1 Year**: XX% -XX% **1-Year High**: XXX% on 2025-02-07 **1-Year Low**: XX% on 2025-06-30 **Most Supportive Themes** - **Pfizer Deal:** (100%) 3SBio signed a $6B outlicensing deal with Pfizer for SSGJ-707, which is the main driver for positive sentiment. **Most Critical Themes** - **None:** (1%) There are currently no critical themes being discussed regarding 3SBio Inc. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | News | X | X% | X | X% | X | X% | | X | XX | XX% | X | X% | X | X% | | Reddit | X | X% | X | X% | X | X% | | YouTube | X | X% | XX | XX% | X | X% | | | | | | | | | | Total | XX | XX% | XX | XX% | X | X% | ### Market Cap: $undefined [#](/topic/$1530hk/market_cap) ---  [Market Cap 24-Hour Chart Data](/topic/$1530hk/time-series/market_cap.tsv) **Current Value**: $undefined **Daily Average**: $XXXXXXXXXXXXXX **1-Year High**: $XXXXXXXXXXXXXX on 2025-04-01 **1-Year Low**: $XXXXXXXXXXXXXX on 2024-11-22 **Top assets mentioned** In the posts about 3SBio Inc. in the last XX hours [Pfizer, Inc. (PFE)](/topic/$pfe) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Bitcoin Incognito (XBI)](/topic/$xbi) [Summit Therapeutics Inc. Common Stock (SMMT)](/topic/$smmt) [Hundred Million (100M)](/topic/$100m) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Innovative Solutions & Support (ISSC)](/topic/$issc) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [Johnson & Johnson (JNJ)](/topic/$jnj) **Top topics mentioned** In the posts about 3SBio Inc. in the last XX hours [stocks healthcare](/topic/stocks-healthcare), [$pfe](/topic/$pfe), [china](/topic/china), [$125b](/topic/$125b), [drugs](/topic/drugs), [investment](/topic/investment), [$6b](/topic/$6b), [pfe](/topic/pfe), [billions](/topic/billions), [$bntx](/topic/$bntx), [lux capital](/topic/lux-capital), [mega](/topic/mega), [$mrk](/topic/$mrk), [marks](/topic/marks), [$xbi](/topic/$xbi), [$smmt](/topic/$smmt), [$9926hk](/topic/$9926hk), [stocks](/topic/stocks), [100m](/topic/100m), [$100m](/topic/$100m), [$bmy](/topic/$bmy), [bloomberg](/topic/bloomberg), [$issc](/topic/$issc), [acquisition](/topic/acquisition), [$12b](/topic/$12b), [wan](/topic/wan), [biontech](/topic/biontech), [$0966hk](/topic/$0966hk), [insurance](/topic/insurance), [$1157hk](/topic/$1157hk), [$0285hk](/topic/$0285hk), [$1211hk](/topic/$1211hk), [cnbc](/topic/cnbc), [trader](/topic/trader), [happened](/topic/happened), [hang seng](/topic/hang-seng), [ip](/topic/ip), [united states](/topic/united-states), [hefty](/topic/hefty), [combo](/topic/combo), [collab](/topic/collab), [50m](/topic/50m), [$50m](/topic/$50m), [$11byear](/topic/$11byear), [$125bn](/topic/$125bn), [$48b](/topic/$48b), [costa rican colon](/topic/costa-rican-colon), [$gild](/topic/$gild), [$jnj](/topic/$jnj), [$lyel](/topic/$lyel), [$zlab](/topic/$zlab), [$legn](/topic/$legn), [vivo](/topic/vivo), [$800m](/topic/$800m), [$35b](/topic/$35b) ### Top Social Posts [#](/topic/$1530hk/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "I am hopeful $pfe pfizer in collaboration with chinese 3SBio will come out with a cancer solution for general public much faster than anyone in the world given their track record. we need to cut down on hospitalizations" [@sigtermsigkill](/creator/x/sigtermsigkill) on [X](/post/tweet/1945810240722862244) 2025-07-17 11:38:07 UTC X followers, X engagements "@news24tvchannel R7 Hold Stock Name: 3SBIO Code:" [@Avadhi_deepak](/creator/x/Avadhi_deepak) on [X](/post/tweet/1945704687644168606) 2025-07-17 04:38:41 UTC 2195 followers, XX engagements "Bourla's enthusiasm may stem from Pfizer's own vested interests evidenced by recent multibillion-dollar licensing deals with Chinese firms like 3SBio" [@Vimalabodhi](/creator/x/Vimalabodhi) on [X](/post/tweet/1945235219709125077) 2025-07-15 21:33:11 UTC 48.6K followers, 4120 engagements "Other multinational players like Merck AstraZeneca Plc and Roche Holding AG have also scooped up Chinese assets. In May Pfizer Inc. set a new record as it announced a $1.2B upfront deal with 3SBio Inc for a cancer drug similar to Akesos. These deals are increasing in both value and frequency signaling confidence that China-originated drugs are competitive internationally and can bring in substantial revenue. The volume of potential candidates coming out of China means multinational companies who have a constant need to add new products to the mix can cast their net wider than ever before. A" [@Byron_Wan](/creator/x/Byron_Wan) on [X](/post/tweet/1944759568594292978) 2025-07-14 14:03:07 UTC 41K followers, 1636 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
3SBio Inc. stock soars following a $X billion deal with Pfizer. Positive sentiment and high engagement are driving the price to an all-time high.
3SBio Inc. is a Chinese biopharmaceutical company.
Price 24-Hour Chart Data
The price surge to an all-time high of $XXXXX is likely due to positive social media sentiment and high engagement surrounding Pfizer's licensing deal and equity investment.
1-Year High: $XXXXX on 2025-07-17
1-Year Low: $XXXX on 2024-11-22
AltRank 24-Hour Chart Data
3SBio Inc. is currently AltRank #undefined based on combined combined social and market metrics
Daily Average: XXXXX
1-Year High: XXXXX on 2025-01-28
1-Year Low: XXX on 2025-03-28
Galaxy Score 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1-Year High: XXX on 2025-03-24
1-Year Low: XX on 2025-02-15
Engagements 24-Hour Chart Data
Current Value: XXX
Daily Average: XXXXX
1 Week: XXXXX -XX%
1 Month: XXXXXX -XX%
6 Months: XXXXXXX +128,724%
1 Year: XXXXXXX +64,494%
1-Year High: XXXXXXX on 2025-05-20
1-Year Low: X on 2025-02-09
Social Network | News | X | YouTube | |
---|---|---|---|---|
Engagements | X | XX | X | XX |
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: XX
1 Week: XX +6.90%
1 Month: XX -XX%
6 Months: XXX +5,333%
1 Year: XXX +1,938%
1-Year High: XXX on 2025-05-20
1-Year Low: X on 2024-08-07
Social Network | News | X | YouTube | |
---|---|---|---|---|
Mentions | X | XX | X | X |
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning 3SBio Inc. in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
1 Week: XX +6.40%
1 Month: XX -XX%
6 Months: XXX +6,050%
1 Year: XXX +2,633%
1-Year High: XXX on 2025-05-20
1-Year Low: X on 2024-08-07
Sentiment 24-Hour Chart Data
Current Value: XXX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% -X%
1 Year: XX% -XX%
1-Year High: XXX% on 2025-02-07
1-Year Low: XX% on 2025-06-30
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
News | X | X% | X | X% | X | X% |
X | XX | XX% | X | X% | X | X% |
X | X% | X | X% | X | X% | |
YouTube | X | X% | XX | XX% | X | X% |
Total | XX | XX% | XX | XX% | X | X% |
Market Cap 24-Hour Chart Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXX on 2025-04-01
1-Year Low: $XXXXXXXXXXXXXX on 2024-11-22
Top assets mentioned In the posts about 3SBio Inc. in the last XX hours
Pfizer, Inc. (PFE) Merck & Co., Inc. (MRK) Bitcoin Incognito (XBI) Summit Therapeutics Inc. Common Stock (SMMT) Hundred Million (100M) Bristol-Myers Squibb Co (BMY) Innovative Solutions & Support (ISSC) Gilead Sciences, Inc. (GILD) Johnson & Johnson (JNJ)
Top topics mentioned In the posts about 3SBio Inc. in the last XX hours
stocks healthcare, $pfe, china, $125b, drugs, investment, $6b, pfe, billions, $bntx, lux capital, mega, $mrk, marks, $xbi, $smmt, $9926hk, stocks, 100m, $100m, $bmy, bloomberg, $issc, acquisition, $12b, wan, biontech, $0966hk, insurance, $1157hk, $0285hk, $1211hk, cnbc, trader, happened, hang seng, ip, united states, hefty, combo, collab, 50m, $50m, $11byear, $125bn, $48b, costa rican colon, $gild, $jnj, $lyel, $zlab, $legn, vivo, $800m, $35b
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"I am hopeful $pfe pfizer in collaboration with chinese 3SBio will come out with a cancer solution for general public much faster than anyone in the world given their track record. we need to cut down on hospitalizations"
@sigtermsigkill on X 2025-07-17 11:38:07 UTC X followers, X engagements
"@news24tvchannel R7 Hold Stock Name: 3SBIO Code:"
@Avadhi_deepak on X 2025-07-17 04:38:41 UTC 2195 followers, XX engagements
"Bourla's enthusiasm may stem from Pfizer's own vested interests evidenced by recent multibillion-dollar licensing deals with Chinese firms like 3SBio"
@Vimalabodhi on X 2025-07-15 21:33:11 UTC 48.6K followers, 4120 engagements
"Other multinational players like Merck AstraZeneca Plc and Roche Holding AG have also scooped up Chinese assets. In May Pfizer Inc. set a new record as it announced a $1.2B upfront deal with 3SBio Inc for a cancer drug similar to Akesos. These deals are increasing in both value and frequency signaling confidence that China-originated drugs are competitive internationally and can bring in substantial revenue. The volume of potential candidates coming out of China means multinational companies who have a constant need to add new products to the mix can cast their net wider than ever before. A"
@Byron_Wan on X 2025-07-14 14:03:07 UTC 41K followers, 1636 engagements
/topic/$1530hk